Page last updated: 2024-11-05

ticlopidine and Rectal Diseases

ticlopidine has been researched along with Rectal Diseases in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Rectal Diseases: Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagata, N1
Niikura, R1
Aoki, T1
Shimbo, T1
Kishida, Y1
Sekine, K1
Tanaka, S1
Okubo, H1
Watanabe, K1
Sakurai, T1
Yokoi, C1
Akiyama, J1
Yanase, M1
Mizokami, M1
Uemura, N1
Iskandarani, MK1
Monem, M1
Mohamed, Z1

Other Studies

2 other studies available for ticlopidine and Rectal Diseases

ArticleYear
Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy.
    Gastrointestinal endoscopy, 2014, Volume: 80, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Clopidogrel; Colonic D

2014
Spontaneous retroperitoneal haematoma resulting in bowel ischaemia.
    BMJ case reports, 2017, Jan-12, Volume: 2017

    Topics: Aged; Clopidogrel; Hematoma; Humans; Male; Mesenteric Ischemia; Peritonitis; Platelet Aggregation In

2017